Experimental Hematology
Volume 38, Issue 10 , Pages 933-944 , October 2010

Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus−infected natural killer cell line established from a patient with hypersensitivity to mosquito bites

Received 11 February 2010 ,Revised 3 April 2010 ,Accepted 14 June 2010.

References 

  1. Rickinson AB, Kieff E. Epstein-Barr virus. In:  Knipe DM,  Howley PM editor. Fields Virology. 4th ed. vol. 2:Philadelphia: Lippincott Williams and Wilkins; 2001;p. 2575–2627
  2. Konno M, Kikuta H, Ishikawa N, Takada K, Iwanaga M, Osato T. A possible association between hepatitis-B antigen-negative infantile popular acrodermatitis and Epstein-Barr virus infection. J Pediatr. 1982;101:222–224
  3. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hamophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259–272
  4. Hidano A, Kawakami M, Yago A. Hypersensitivity to mosquito bite and malignant histiocytosis. Jpn J Exp Med. 1982;52:569–578
  5. Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol. 2001;45:569–578
  6. Iwatsuki K, Yamamoto T, Tsuji K, et al. A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections. Acta Med Okayama. 2004;58:169–180
  7. Kawa K, Okamura T, Yagi K, Takeuchi M, Nakayama M, Inoue M. Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood. 2001;98:3173–3174
  8. Jones J, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic active EBV infections. N Engl J Med. 1988;318:733–741
  9. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol. 1997;54:276–281
  10. Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol. 1999;115:385–392
  11. Yagita M, Huang CL, Umehara H, et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia. 2000;14:922–930
  12. Xu ZG, Iwatsuki K, Oyama N, et al. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. Br J Cancer. 2001;84:920–925
  13. Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 1998;165:75–86
  14. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006;214:56–72
  15. Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97:3146–3151
  16. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood. 2002;100:1935–1947
  17. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990;76:2421–2438
  18. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20:323–370
  19. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376
  20. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev. 2006;20:123–137
  21. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001;25:11521–11526
  22. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001;413:165–171
  23. Loza MJ, Zamai L, Azzoni L, Rosati E, Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood. 2002;99:1273–1281
  24. Tosato G, Jones K, Breinig MK, McWilliams HP, McKnight JL. Interleukin-6 production in posttransplant lymphoproliferative disease. J Clin Invest. 1993;91:2806–2814
  25. Trinchieri G. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol. 1995;7:83–88
  26. Cen H, McKnight JL. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines. Virus Res. 1994;31:89–107
  27. Kanamori M, Tajima M, Satoh Y, et al. Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji. Virus Genes. 2000;20:117–125
  28. Countryman JK, Gradoville L, Miller G. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J Virol. 2008;82:4706–4719
  29. Loza MJ, Perussia B. Final steps of natural killer cells maturation: a general model for type 1-type 2 differentiation?. Nat Immunol. 2001;2:917–924
  30. Mizuki M, Ueda S, Tagawa S, et al. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol. 1998;59:309–315
  31. Seo N, Tokura Y, Ishihara S, Takeoka Y, Tagawa S, Takigawa M. Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites. Clin Exp Immunol. 2000;120:413–419
  32. Yamamoto T, Fujii K, Tsuji K, et al. Characterization of Epstein-Barr virus-infected natural killer lymphocytes in a patient with hypersensitivity to mosquito bites. J Am Acad Dermatol. 2005;53:912–914

PII: S0301-472X(10)00240-7

doi: 10.1016/j.exphem.2010.06.005

Experimental Hematology
Volume 38, Issue 10 , Pages 933-944 , October 2010

Article Tools

* Image Usage & Resolution